130 related articles for article (PubMed ID: 29132997)
1. Thyroid hormone improves insulin signaling and reduces the activation of neurodegenerative pathway in the hippocampus of diabetic adult male rats.
Prieto-Almeida F; Panveloski-Costa AC; Crunfli F; da Silva Teixeira S; Nunes MT; Torrão ADS
Life Sci; 2018 Jan; 192():253-258. PubMed ID: 29132997
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats.
Panveloski-Costa AC; Silva Teixeira S; Ribeiro IM; Serrano-Nascimento C; das Neves RX; Favaro RR; Seelaender M; Antunes VR; Nunes MT
Acta Physiol (Oxf); 2016 Jun; 217(2):130-40. PubMed ID: 26748816
[TBL] [Abstract][Full Text] [Related]
3. Therapeutical Potential of T3 as Adjuvant Therapy in Male Alloxan-induced Diabetic Rats.
Florido Neto AR; Agostini L; Silva LPD; Nunes MT
Endocrinology; 2024 May; 165(7):. PubMed ID: 38862394
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats.
Bathina S; Srinivas N; Das UN
Biochem Biophys Res Commun; 2017 Apr; 486(2):406-413. PubMed ID: 28315336
[TBL] [Abstract][Full Text] [Related]
6. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats.
Ortiz-Caro J; González C; Jolin T
Endocrinology; 1984 Dec; 115(6):2227-32. PubMed ID: 6238818
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
8. Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease.
Maglione AV; do Nascimento BPP; Ribeiro MO; de Souza TJL; da Silva REC; Sato MA; Penatti CAA; Britto LRG; de Souza JS; Maciel RMB; da Conceição RR; Laureano-Melo R; Giannocco G
Metab Brain Dis; 2022 Dec; 37(8):2735-2750. PubMed ID: 35951206
[TBL] [Abstract][Full Text] [Related]
9. Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats.
King MR; Anderson NJ; Liu C; Law E; Cundiff M; Mixcoatl-Zecuatl TM; Jolivalt CG
Neuroscience; 2015 Sep; 303():220-8. PubMed ID: 26149351
[TBL] [Abstract][Full Text] [Related]
10. Maternal diabetes mellitus, a rat model for nonthyroidal illness: correction of hypothyroxinemia with thyroxine treatment does not improve fetal thyroid hormone status.
Calvo R; Morreale de Escobar G; Escobar del Rey F; Obregón MJ
Thyroid; 1997 Feb; 7(1):79-87. PubMed ID: 9086576
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction.
Xiang Q; Zhang J; Li CY; Wang Y; Zeng MJ; Cai ZX; Tian RB; Jia W; Li XH
Neuropeptides; 2015 Dec; 54():9-15. PubMed ID: 26344332
[TBL] [Abstract][Full Text] [Related]
12. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway.
Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S
Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132
[TBL] [Abstract][Full Text] [Related]
13. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.
Réus GZ; Bernardini Dos Santos MA; Abelaira HM; Maciel AL; Arent CO; Matias BI; Bruchchen L; Ignácio ZM; Michels M; Dal-Pizzol F; Carvalho AF; Zugno AI; Quevedo J
Curr Neurovasc Res; 2016; 13(2):107-14. PubMed ID: 26891662
[TBL] [Abstract][Full Text] [Related]
15. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
16. Diabetes decreases liver and kidney nuclear 3,5,3'-triiodothyronine receptors in rats.
Jolin T
Endocrinology; 1987 May; 120(5):2144-51. PubMed ID: 3552632
[TBL] [Abstract][Full Text] [Related]
17. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.
Collino M; Aragno M; Castiglia S; Tomasinelli C; Thiemermann C; Boccuzzi G; Fantozzi R
Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
19. Fish oil modulates glycogen synthase kinase-3 signaling pathway in diabetes-induced hippocampal neurons apoptosis.
Sun LJ; Hou XH; Xue SH; Yan F; Dai YJ; Zhao CH; Wang F; Yang RH
Brain Res; 2014 Jul; 1574():37-49. PubMed ID: 24924805
[TBL] [Abstract][Full Text] [Related]
20. Effect of triiodothyronine administration on reduced expression of type 1 iodothyronine deiodinase messenger ribonucleic acid in streptozotocin-induced diabetic rats.
Tabata S; Nishikawa M; Toyoda N; Yonemoto T; Ogawa Y; Inada M
Endocr J; 1999 Jun; 46(3):367-74. PubMed ID: 10503988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
